Clinical Study of Shang gan Granules in Treating Mild Influenza

Institute of Traditional Chinese Medicine and Clinical Medicine, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Those who meet the diagnostic criteria of clinically diagnosed cases and/or confirmed cases of Western medicine for influenza;
•2. Those who meet the criteria of TCM syndrome differentiation for influenza (mild);
•3. Acute respiratory tracts such as stuffy nose, runny nose, sore throat, cough, etc. Symptoms and/or accompanied by fever (formally measured axillary temperature of more than 5 minutes >= 37.5 degrees C, < 39.0 degrees C;
•4. Age 14-70 years.
•5. Course of disease <= 48 hours.
•6. Previous physical fitness, no diseases other than influenza Diagnosis history and related medication history;
•7. Voluntarily participating in this study and signing informed consent.

•1. Patients diagnosed with tuberculosis, measles and AIDS combined with pneumocystis and other infectious diseases;
•2. Those who are known to be allergic to the Chinese medicine ingredients or Western medicine used in this study;
•3. Serious basic diseases such as heart, brain, lung, liver, kidney and blood system, such as patients with viral hepatitis, hemophilia, and psychosis;
•4. patients with immunodeficiency or taking immunosuppressive agents or glucocorticoids within the past 3 months;
•5. Before taking treatment, other internal medicines against the disease have been received, such as antiviral drugs, antibiotics, traditional Chinese medicine, etc.;
•6. Those who have been vaccinated with influenza vaccine within 3 months before the consultation;
•7. Pregnancy or puerperium women, unstable living environment, work place Patients who are likely to cause loss of follow-up due to frequent changes, or others who are unable or unwilling to cooperate;
•8. Participate in other trials in the past 3 months.

发起方

Institute of Traditional Chinese Medicine and Clinical Medicine, China Academy of Chinese Medical Sciences